AU Patent

AU2002243751A1 — Detection of herpes simplex virus

Assigned to Mayo Clinic in Florida · Expires 2002-08-12 · 24y expired

What this patent protects

The invention provides methods to detect herpes simplex virus (HSV) in biological samples and further to distinguish between HSV-1 and HSV-2. Primers and probes for the differential detection of HSV-1 and HSV-2 are provided by the invention. Articles of manufacture containing suc…

USPTO Abstract

The invention provides methods to detect herpes simplex virus (HSV) in biological samples and further to distinguish between HSV-1 and HSV-2. Primers and probes for the differential detection of HSV-1 and HSV-2 are provided by the invention. Articles of manufacture containing such primers and probes for detecting HSV are further provided by the invention.

Drugs covered by this patent

Patent Metadata

Patent number
AU2002243751A1
Jurisdiction
AU
Classification
Expires
2002-08-12
Drug substance claim
No
Drug product claim
No
Assignee
Mayo Clinic in Florida
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.